Working to Eradicate Gynecologic Cancers

Ana Isabel Tergas, MD, MPH

Assistant Professor
NYP/Columbia University Medical Center
630 W 168th St
New York, NY
USA 10032

Papers:
43 Identification of potential therapeutic targets by molecular profiling of 628 cases of uterine serous carcinoma 64 High versus low-dose rate brachytherapy for locally advanced cervical cancer 92 Ovarian cancer patients selected for neoadjuvant chemotherapy vs. primary debulking surgery are not similar: a National Cancer Data Base study 115 Sexual and marital dysfunction in women with gynecologic cancer: results of a multi-institutional, cross-sectional trial 119 Measurement and validation of frailty as a predictor of outcomes in women undergoing major gynecologic surgery 141 Molecular characterization of 361 cases of uterine carcinosarcomas reveal alterations in the DNA repair and PI3K pathways as potential therapeutic targets 229 Population-level survival trends for uterine cancer 240 Identifying potential therapeutics by molecular profiling of 136 cases of uterine clear cell carcinoma 275 Secular trends in relative survival for ovarian cancer 300 A systematic review of radiotherapy resources in low and middle income countries 383 Distinct molecular landscapes between endometrioid and non-endometrioid uterine carcinoma 436 Risk stratification and outcomes of women undergoing surgery for ovarian cancer 463 Refusal of recommend chemotherapy for ovarian cancer: risk factors and outcomes, a National Cancer Database study 476 Real world effectiveness of minimally invasive hysterectomy for uterine cancer Robot-assisted radical trachelectomy: surgical techniques Transition into the next phase